EDAP TMS SA
EDAPStock
$4.32+256.07%52W
Market Cap$177.62M
P/E—
Div yield—
Beta-0.00
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)44.02%
Price vs S&P 500 (4W)14.04%
VGM Score64.14
Market Capitalization$177.62M
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.89
3.89
3.89
3.89
Industry Peers — Electromedical Equipment(32)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
EDAPEDAP TMS SA | C | B | A | $4.32 |
| MDTMedtronic plc | B | C | C | $83.56 |
| MASIMasimo Corporation | D | D | C | $179.95 |
| LIVNLivaNova PLC Ordinary Shares | C | C | B | $81.79 |
| ITGRInteger Holdings Corporation | B | C | B | $99.62 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | $76.00 |
| AXGNAxogen, Inc. Common Stock | F | B | B | $39.77 |
| BLFSBioLife Solutions Inc. | F | B | A | $30.26 |
| CNMDCONMED Corporation | A | C | B | $45.01 |
| INMDInMode Ltd. Ordinary Shares | A | D | B | $15.60 |
| CBLLCeriBell, Inc. Common Stock | D | A | C | $19.14 |
About
Edap TMS SA develops and markets ultrasound-based medical devices for urology and oncology, with three core divisions: HIFU technology for minimally invasive tumor treatment, ESWL systems for kidney stone lithotripsy, and a distribution channel for complementary medical products. The company generates revenue from both proprietary device sales and service of its global installed base across North America, Europe, and Asia.